Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| RTU-Q | ATOMS F.D. INC | Marketed | Feb 23, 2022 | Marketed |
| RILEXINE CHEWABLE TABLETS | VIRBAC AH, INC. | Marketed | Feb 23, 2022 | Marketed |
| RILEXINE CHEWABLE TABLETS | VIRBAC AH, INC. | Marketed | Feb 23, 2022 | Marketed |
| TRANEXAMIC ACID | Jamp Pharma Corporation | Marketed | Feb 23, 2022 | Marketed |
| NGENLA | Pfizer Canada Ulc | Marketed | Feb 22, 2022 | Marketed |
| FLEXACRÈME PAIN RELIEF RUB | crls | Marketed | Feb 22, 2022 | Marketed |
| JEMPERLI | GlaxoSmithKline Inc | Marketed | Feb 22, 2022 | Marketed |
| NGENLA | Pfizer Canada Ulc | Marketed | Feb 22, 2022 | Marketed |
| JAMP ABACAVIR / LAMIVUDINE | Jamp Pharma Corporation | Marketed | Feb 22, 2022 | Marketed |
| SELECTION DISINFECTING WIPES | ROCKLINE INDUSTRIES | Marketed | Feb 21, 2022 | Marketed |
| JAMP MIDODRINE | Jamp Pharma Corporation | Marketed | Feb 21, 2022 | Marketed |
| REFRESH ANTIBAC FOAM | sc johnson professional ca inc | Marketed | Feb 21, 2022 | Marketed |
| JAMP MIDODRINE | Jamp Pharma Corporation | Marketed | Feb 21, 2022 | Marketed |
| OXERVATE | Dompe Farmaceutici SpA | Cancelled Post Market | Feb 18, 2022 | Cancelled Po... |
| ALTREN SOLUTION 0.22% | AURORA PHARMACEUTICAL, INC. | Marketed | Feb 17, 2022 | Marketed |
| THYMOX MULTISURFACE | LABORATOIRE M2 INC | Cancelled (Transitioned To Biocides) | Feb 17, 2022 | Cancelled (T... |
| SALINE 0.9% | DMVET INC | Marketed | Feb 17, 2022 | Marketed |
| JAMP CLOXACILLIN | Jamp Pharma Corporation | Marketed | Feb 17, 2022 | Marketed |
| JAMP CLOXACILLIN | Jamp Pharma Corporation | Marketed | Feb 17, 2022 | Marketed |
| AURO-SILODOSIN | auro pharma inc | Marketed | Feb 16, 2022 | Marketed |
